Published in Biol Psychiatry on February 01, 1985
Reflexes in psychiatry. Innov Clin Neurosci (2011) 0.79
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry (2004) 1.76
Gender-related clinical differences in older patients with schizophrenia. J Clin Psychiatry (1999) 1.49
Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry (1989) 1.21
Conventional vs. newer antipsychotics in elderly patients. Am J Geriatr Psychiatry (1999) 1.18
Did schizophrenia exist before the eighteenth century? Compr Psychiatry (1986) 1.11
Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry (1993) 1.07
High prevalence of visual hallucinations in research subjects with chronic schizophrenia. Am J Psychiatry (1989) 1.05
New pathway for delta-aminolevulinic acid biosynthesis: formation from alpha-ketoglutaric acid by two partially purified plant enzymes. Biochem Biophys Res Commun (1976) 1.03
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry (1993) 0.99
Gender, estrogen, and schizophrenia. Psychopharmacol Bull (1997) 0.97
Neuroanatomical studies of major affective disorders. A review and suggestions for further research. Br J Psychiatry (1988) 0.96
Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study. Curr Pharmacogenomics Person Med (2009) 0.92
Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394. Psychopharmacology (Berl) (1997) 0.91
Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia. Acta Psychiatr Scand (1994) 0.90
Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E. Ann N Y Acad Sci (1989) 0.88
The role of psychiatrists in primary care of patients with severe mental illness. Psychiatr Serv (2000) 0.87
Sensorimotor disinhibition in Parkinson's disease: effects of levodopa. Ann Neurol (1992) 0.87
A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients. Biol Psychiatry (1994) 0.85
Scaling of movement velocity: a measure of neuromotor retardation in individuals with psychopathology. Psychophysiology (1998) 0.84
Cerebellar pathology in schizophrenia? A neuronometric study. Biol Psychiatry (1986) 0.84
Hippocampal pyramidal cells and aging in the human: a quantitative study of neuronal loss in sectors CA1 to CA4. Exp Neurol (1986) 0.83
Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis. Clin Neuropharmacol (1993) 0.81
An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (1997) 0.81
A treatment outcome study of community-based residential care. Hosp Community Psychiatry (1994) 0.80
Recognition and treatment of depression in Alzheimer's disease. Geriatrics (1989) 0.80
Alpha-tocopherol in tardive dyskinesia. Lancet (1987) 0.79
A potential mechanism underlying the voluntary suppression of tardive dyskinesia. J Psychiatr Res (1989) 0.78
Diazepam for catatonia. Am J Psychiatry (1984) 0.78
Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats. Psychopharmacology (Berl) (1992) 0.78
Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biol Psychiatry (2001) 0.77
Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand. J Neuropsychiatry Clin Neurosci (1990) 0.77
Adverse neurobiological effects of long-term use of neuroleptics: human and animal studies. J Psychiatr Res (1998) 0.77
Subtle signs of prenatal maldevelopment of the hand ectoderm in schizophrenia: a preliminary monozygotic twin study. Biol Psychiatry (1991) 0.77
Extrapyramidal motor abnormalities associated with late-life psychosis. Schizophr Bull (1993) 0.77
Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biol Psychiatry (1991) 0.76
Pharmacological treatments of tardive dyskinesia in the 1980s. J Clin Psychopharmacol (1988) 0.76
Comparison of outcomes of acute care in short-term residential treatment and psychiatric hospital settings. Psychiatr Serv (1999) 0.76
Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophrenia. Psychiatry Res (1992) 0.76
Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients. J Neuropsychiatry Clin Neurosci (1997) 0.75
Asymmetry of neuroleptic-induced rigidity: development of quantitative methods and clinical correlates. Psychiatry Res (1989) 0.75
Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates. Psychopharmacol Bull (1987) 0.75
Increased cerebrospinal fluid cyclo(His-Pro) content in schizophrenia. Neuropeptides (1991) 0.75
Instrumental evidence that age increases motor instability in neuroleptic-treated patients. J Gerontol (1991) 0.75
Effects of alcohol on symptoms in alcoholic and nonalcoholic patients with schizophrenia. Hosp Community Psychiatry (1994) 0.75
Relationship of gender and age at onset of schizophrenia to severity of dyskinesia. J Neuropsychiatry Clin Neurosci (2001) 0.75
Surgery for Parkinson's disease: is the graft really necessary? J Neuropsychiatry Clin Neurosci (1989) 0.75
Fluctuation of tardive dyskinesia. Biol Psychiatry (1995) 0.75
Pharmacists' role in clozapine therapy at a Veterans Affairs medical center. Am J Hosp Pharm (1994) 0.75